HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAB5. A total of 15 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $24,079,000 | +8.2% | 12,750,000 | 0.0% | 0.54% | +24.9% |
| Q1 2022 | $22,252,000 | -0.2% | 12,750,000 | 0.0% | 0.43% | -6.9% |
| Q4 2021 | $22,298,000 | +11.0% | 12,750,000 | +13.3% | 0.47% | +1.1% |
| Q3 2021 | $20,091,000 | -8.9% | 11,250,000 | 0.0% | 0.46% | -3.8% |
| Q2 2021 | $22,065,000 | +8.8% | 11,250,000 | +2.3% | 0.48% | -8.4% |
| Q1 2021 | $20,287,000 | – | 11,000,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | 33,153,000 | $64,904,000 | 0.49% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,250,000 | $22,065,000 | 0.48% |
| SSI INVESTMENT MANAGEMENT LLC | 3,573,000 | $6,973,000 | 0.45% |
| MIZUHO SECURITIES USA LLC | 1,300,000 | $2,542,000 | 0.21% |
| LINDEN ADVISORS LP | 10,703,000 | $20,965,000 | 0.11% |
| Calamos Advisors LLC | 10,000,000 | $19,564,000 | 0.09% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,000,000 | $3,915,000 | 0.09% |
| BNP PARIBAS FINANCIAL MARKETS | 3,294,000 | $6,460,344,000 | 0.01% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,000,000 | $1,956,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 4,000,000 | $7,824,000 | 0.01% |